In order to solve the dilemma of rising prescription drug costs, a health insurer and a pharmaceutical company recently announced a collaborative initiative to re-focus the discussion on drug payments away from price and towards the best outcomes for each patient. They plan to introduce performance and value-based pricing. Click here to read more.
Last Updated on May 8, 2020 by Aimed Alliance
